Skip to main content
. Author manuscript; available in PMC: 2019 Jun 7.
Published in final edited form as: Recent Pat CNS Drug Discov. 2012 Aug;7(2):129–144. doi: 10.2174/157488912800673128

Fig. (1).

Fig. (1).

Typical data from the “differential” molecular screen showing inhibition of [3H]MK801 binding in the presence (upper curves) and absence (lower curves) of potentiation by 100μM spermidine. The data are presented as untransformed DPM rather than as % specific binding, because the upper curves represent inhibition of time-dependent potentiation of [3H]MK801 binding by spermidine.